Abstract
purpose. To study the neuroprotective effect of experimental retinal detachment (RD) on photoreceptor degeneration in rd1 mice.
methods. RD was produced in the eyes of rd1 mice at postnatal day (P) 9. These eyes were collected and compared to controls without RD. The effects of RD on retinal degeneration were evaluated by histochemical staining of nuclei in the outer nuclear layer (ONL), rod and cone photoreceptors, and retinal vessels at P30 in retinal sections and flatmounts. Apoptotic photoreceptors were detected by TdT-mediated dUTP nick-end labeling (TUNEL) at P15. Mice with or without RD were also reared in darkness and evaluated immunohistochemically at P30.
results. The numbers of rhodopsin-positive (rod), peanut agglutinin-positive (cone), and diamino-2-phenyl-indol-stained (rod-plus-cone) cells in the ONL were increased by 2.0-fold, 1.3-fold, and 1.2-fold, respectively, in the rd1 eyes with RD compared to those without RD at P30. In the detached retina, the cone photoreceptor inner/outer segment structures and the deep retinal vessels surrounding the inner nuclear layer and the ONL, but not the ganglion cell layer, were preserved. At P15, TUNEL-positive cell numbers in the ONL were significantly reduced in the eyes with RD. Light exposure had no effect on photoreceptor degeneration in the eyes with or without RD.
conclusions. RD mediates the preservation of cone and rod photoreceptors in the ONL and surrounding vascular structures by reducing the rate of apoptosis of photoreceptors in rd1 mice. Light deprivation does not appear to be one of the mechanisms of photoreceptor protection in the detached retinas in these mice.
Retinitis pigmentosa (RP) is a group of inherited human eye diseases that affects approximately 1 in 4000 persons. The disease is clinically characterized by the progressive loss of rod photoreceptors followed by cone photoreceptor degeneration and vessel attenuation.
1 In the early stages of the disease, affected patients show evidence of rod photoreceptor dysfunction/degeneration, such as night blindness or constriction of the visual field. Later stages of the disease are characterized by additional symptoms related to cone photoreceptor dysfunction/degeneration, which eventually results in loss of central vision.
1 2 To date, genetic defects in more than 45 genes have been identified as causes of this disease
3 (http://www.sph.uth.tmc.edu/RetNet/home.htm). In particular, recessive defects in the gene encoding the β-subunit of cyclic GMP phosphodiesterase have been identified as causes not only of RP in humans
4 5 but also of retinal degeneration in mice widely used for the eye research (
rd1 mice).
6 7
In
rd1 mice, rapid rod photoreceptor degeneration begins at approximately postnatal day (P)10, with most of the cells degenerated by P30.
8 9 Consequently, the remaining photoreceptors at this age are mostly cones.
8 These cone photoreceptors are distributed unevenly across the retina at P30, and their concentration decreases first in the central and far peripheral retina, leaving a ring of cells in the midperipheral region.
10 Retinal vessels begin to degenerate at approximately the second week, and by P30 vessel lengths are reduced by approximately 50%.
11
We have been searching for factors that may delay the process of photoreceptor degeneration by protecting them from apoptosis or promoting their regeneration in
rd1 mice. Vascular endothelial growth factor (VEGF), a known angiogenic factor, has been shown to stimulate one of its ligands, VEGFR2/Flk1, expressed in retinal progenitor cells to promote their proliferation at the peripheral retina in these mice.
12 During the course of the VEGF study, we found that intravitreal injection of VEGF in
rd1 mice often induced retinal detachment (RD) from the underlying retinal pigment epithelium (RPE), the mechanism of which was unknown. Interestingly, among the eyes injected with VEGF, those with RD clearly and consistently had more photoreceptors than those without. This observation was unexpected because RD is a blinding disease known to cause slow photoreceptor apoptosis in humans
13 14 15 and mice.
16 17 18 Although the precise molecular pathology of retinal degeneration in RD is still unclear, photoreceptor apoptosis is mediated through pathways dependent or independent of caspases.
13 14 15 16 18 19 20 21 Moreover, such photoreceptor apoptosis is partially promoted by the recruitment of macrophages into the detached retina through monocyte chemoattractant protein 1, expressed by Müller glial cells.
18 On the other hand, it has been reported that the progression of photoreceptor loss in
rd1 mice was delayed by removing the retina from the RPE and keeping it in culture,
22 23 24 whereas similar tissue culture of retinas from wild-type mice resulted in fewer photoreceptor layers.
22 24 Survival factors in the medium have been postulated as among the mechanisms for the observed photoreceptor preservation in retinal culture from
rd1 mice.
23
In this study, we defined the influence of RD on the rd1 retina by statistical analysis of its effect on the numbers of surviving and apoptotic photoreceptors. We showed that experimentally induced RD preserved photoreceptors and the surrounding retinal vasculatures by reducing apoptosis of photoreceptors in rd1 mice.
Histochemical analyses were performed on eyes enucleated at P30, as described previously
12 with some modifications. To evaluate histologic sections, the eyes were enucleated after cauterization of the superior cornea for orientation. The cornea and lens were removed from the eyes, which were fixed with 4% paraformaldehyde (PFA) for 2 hours, cryoprotected with 30% sucrose at 4°C overnight, and processed through the ventral to dorsal meridian into sections 10 μm thick. These sections were permeabilized with 0.01% Triton X-100/PBS (PBST) for 5 minutes, blocked with 5% goat serum/PBS for 1 hour, and incubated with a first antibody for 1 hour and a second antibody for 1 hour. For analysis of retinal flatmount specimens, eyecups were fixed with 4% PFA and the entire retina was dissected from the RPE and incised radially for each sample. For evaluation of the vascular structures, samples were permeabilized with 0.5% PBST for 3 hours, blocked in 5% goat serum/PBS for 1.5 hours, and incubated with a primary antibody for 12 hours and with a secondary antibody for 6 hours. For analysis of cone photoreceptor inner/outer segments, the flatmounts were permeabilized with 0.5% PBST for 3 hours and incubated in fluorescent dye–conjugated peanut agglutinin (PNA; Alexa 488,1:100; Molecular Probes, Eugene, OR) for 6 hours.
Specimens were incubated with first antibodies against rhodopsin (1:1500; Chemicon, Temecula, CA), M-cone opsin (1:1000; Chemicon), or collagen IV (1:500; Neomarkers, Vancouver, WA) followed by staining with fluorescent dye–conjugated antibody (Alexa 488, 1:1500; Molecular Probes) and diamino-2-phenyl-indol (DAPI; 1:1000, Molecular Probes). The same concentrations of antibodies were applied to sections and flatmount specimens.
In 600-μm wide portions of the central retina and at equal distances from the anterior margin of the optic nerve and the posterior margin of the ciliary body, DAPI-positive nuclei, rhodopsin-positive cells, or TUNEL-positive cells were evaluated from histologic sections of the outer nuclear layer (ONL). DAPI-positive nuclei and rhodopsin-positive cells in the ONL were counted from a single image, whereas TUNEL-positive cells in the ONL were counted from three independent images and averaged. Numbers of DAPI-positive nuclei or rhodopsin-positive cells were normalized by retinal thickness (average of three independent measurements) measured within the same image to reduce the effect of the tangential sectioning of the retina. The average retinal thickness from untouched P30 rd1 mice (n = 11) was used as a reference.
Numbers of collagen IV-positive retinal vessel lumens in three major layers in which the vascular networks were most highly concentrated
25 —the nerve fiber layer/ganglion cell layer (NFL/GCL), the inner plexiform layer (IPL), and the inner nuclear layer/outer plexiform layer (INL/OPL)—were determined from three independent images of retinal sections and averaged.
Numbers of PNA-positive cone photoreceptor inner/outer segments within a 320 μm × 320 μm square located 1 mm dorsal and ventral to the optic nerve were determined and averaged from images obtained from flatmounts. All experimental data were evaluated by an operator masked to the treatment conditions (RD, non-RD, or untouched). Differences were examined using the unpaired Student t-test, and P < 0.05 was considered significant.
We found significantly more rod and cone photoreceptors in detached than in nondetached
rd1 retinas. This neuroprotective effect of RD on photoreceptors was likely mediated by reduced apoptosis. We also found preservation of the inner/outer segment structures of M-cone photoreceptors and retinal vascular plexus, both of which are likely to be secondary effects.
8 9 10 11 25
Rod photoreceptors are primarily affected because of defects in the gene
Pde6b encoding the rod photoreceptor-specific phosphodiesterase in
rd1 mice.
6 7 It is reasonable then to assume that the induction of RD preferentially protects diseased rod photoreceptors from apoptosis. This was supported by the observation that the number of rhodopsin-positive rod photoreceptors was increased by approximately 2-fold compared with the nondetached retina, whereas DAPI-positive nuclei in the ONL, representing the sum of rod and cone photoreceptors, was increased by only approximately1.2-fold at P30. Given that more than 90% of photoreceptors in the ONL are cone photoreceptors at this stage in the
rd1 retina,
8 these results suggested that cone photoreceptors are also preserved, though to a lesser degree. This finding was further supported by the quantification of the PNA-positive inner/outer segments of cone photoreceptors in retinal flatmounts, which were increased by approximately 1.3-fold in the detached retinas.
Although we found that the neuroprotective effect of RD on photoreceptor degeneration was probably mediated by the reduction of apoptosis, the precise mechanism of the neuroprotective effect remains unclear. One of the most feasible factors contributing to the rescue effects is the widely known upregulation of neurotrophic factors or cytokines induced by ocular injuries in rodents
33 34 35 36 37 and in humans.
38 39 40 However, unlike other forms of trauma known to be neuroprotective against retinal degeneration, such as puncture
34 36 41 42 or lens injury,
43 44 45 RD is directly toxic to photoreceptors and induces their apoptosis in wild-type mice.
16 17 18 Therefore, the degree to which upregulated cytokines or neurotrophic factors counteract photoreceptor degeneration is unclear. At the same time, it is possible that important factors, in addition to the injury itself, may account for the observed paradoxical neurotrophic effect of RD on photoreceptors in
rd1 mice.
A pathway of photoreceptor apoptosis dependent on phototransduction has been described in mice with retinal degeneration.
33 46 Moreover, light deprivation has been reported to protect retinal neurons in other rodent models of retinal degeneration.
31 32 Because the defective gene in
rd1 mice,
Pde6b, encodes an essential component of the phototransduction cascade, we initially postulated that the reduction of aberrant visual transduction in
rd1 eyes with RD may protect photoreceptors from apoptosis. However, further experiments revealed that this hypothesis does not apply to RD-induced neuroprotection in
rd1 mice. Other factors—such as separation of the retina from the RPE, which is involved in phagocytosis of the subretinal debris,
47 48 and reduction of excessive oxidative supply from the choroidal circulation, which results in reduced oxidative stress
49 —are under evaluation.
Analyses of the collagen IV-positive vascular structures showed significant preservation of the small caliber vessels in the deeper retina but not the larger vessels around the GCL. The greatest effect was observed in the deepest vascular network at the interface between the INL and the severely attenuated OPL, which showed an increase of approximately 8.2-fold in the number of vascular lumens in the eyes compared to those without RD. The anatomic proximity of these vessels and the adjacent photoreceptors indicate that preservation of these two retinal components is related, which is consistent with the hypothesis that vascular structures are preserved secondarily to the protection of photoreceptors from apoptosis. The greater amount of blood needed in the deeper retinal layers because of the increased number of remaining photoreceptors may account for the preservation of deep vascular plexus.
Our finding that RD, a known blinding disease that results in photoreceptor degeneration and severely reduced visual transduction, could have a protective effect against photoreceptor apoptosis is unique and unexpected, though the underlying mechanisms are still unclear. This study also indicates the need for careful evaluation of data involving subretinal injection of neurotrophic substances or cells accompanied by the presence of RD in rodents with retinal degeneration, particularly rd1 mice.
Supported by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (B16390497, B18390466, C19592013) and a Grant-in Aid from the Ministry of Health, Labor, and Welfare of Japan, Tokyo, Japan.
Submitted for publication June 14, 2007; revised August 21 and October 23, 2007; accepted December 14, 2007.
Disclosure:
H. Kaneko, None;
K.M. Nishiguchi, None;
M. Nakamura, None;
S. Kachi, None;
H. Terasaki, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Koji M. Nishiguchi, Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan;
[email protected].